Pricing Log in Create free account

Bright Minds Biosciences Inc. (DRUG) vs Cartesian Therapeutics, Inc. (RNAC)

Bright Minds Biosciences Inc. and Cartesian Therapeutics, Inc. are both Biotechnology companies. Bright Minds Biosciences Inc. and Cartesian Therapeutics, Inc. are of similar size ($229.7M and $226.9M). Across the 9 metrics below, Cartesian Therapeutics, Inc. leads on 5 and Bright Minds Biosciences Inc. on 4.

Valuation

Metric DRUG RNAC Biotechnology median
P/E n/m n/m 10.60
P/S n/m 125.01 9.40
P/B 1.02 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 77.39 9.02
Earnings yield (9.04%) (78.75%) (32.88%)
Free cash flow yield (7.85%) (35.43%) (23.13%)

Profitability

Metric DRUG RNAC Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (13.64%) 236.88% (51.96%)
Return on assets (13.52%) (42.77%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DRUG RNAC Biotechnology median
Revenue growth (TTM) — (94.81%) 6.76%
EPS growth (last fiscal year) (164.58%) (11.80%) 29.88%
Revenue growth, 5-year CAGR — (29.96%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DRUG RNAC Biotechnology median
Debt to equity 0.00 (0.42) 0.00
Current ratio 121.98 7.48 4.97
Net debt to EBITDA 5.98 0.89 1.01

Dividend

Metric DRUG RNAC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DRUG RNAC Biotechnology median
Market cap 226.87m 229.69m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack